|Zhenyu Guo, Ph. D., Chairman and CEO, Dihon Pharmaceutical Co. Ltd., Kunming, China, has been elected Chairman-Elect of the World Self-Medication Industry (WSMI) by the WSMI Board. Dr Guo will take up the Chairmanship following the completion of current Chairman Mr Christopher Combe’s term of office in October 2011. Dr Guo currently serves as WSMI Board Member and is Executive Chairman of the China Nonprescription Medicines Association (CNMA), WSMI’s member association in China.|
Dr Guo’s exceptional career extends to both the academic and private sectors, and around the world in China, Canada and the USA. Dr Guo has been Chairman and CEO of Dihon Pharmaceuticals since January 2003. Prior to joining Dihon Pharma he was Professor and Director of the Laboratory of Biomedical Engineering, the George Washington University, Washington DC, USA. Dr. Guo holds a Ph. D. in Electrical Engineering of McGill University, Canada and a M.S. in Electrical Engineering of Yunnan University, China (1986). He conducted post-doctoral research in Biomedical Engineering in Western Ontario University, Canada.
Since commencing at Dihon Pharma Dr Guo has received many awards including the “Achievement Award for China’s Medication Industry” (2009), the “Outstanding Award for the Development of China’s Self-Medication Industry” (2009), the “China Outstanding Entrepreneur Award” (2007), the “Asia 10 Most Influential Brand Personality Award” (2007), the Outstanding Chinese Private Science & Technology Entrepreneurs” (2007 & 2003) and the “Outstanding Pioneering Prize for Overseas Chinese Specialists” (2005).